In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the ...

Further to the pre-stabilisation period announcement dated 8 th January 2025, Natixis (contact: Jean Dado; telephone: +44 20 32 16 95 60 / contact: Terence Sands; telephone: +44 20 32 16 92 40) hereby ...

Aggregated information on Shares purchased according to trading venue: In respect of this programme, Natixis will make trading decisions in relation to the securities independently of the Company for ...

Chinese producers, facing weak demand at home and harsher conditions in the United States, where they sell more than US$400 ...

LONDON - Natixis Syndicate has announced that no stabilisation actions were undertaken following the issuance of Tereos ...

Equities research analysts at William Blair decreased their Q1 2025 earnings per share estimates for shares of AptarGroup in ...

Market Overview Analysis by Newsquawk Voice Ltd (Ryan Anderson) covering: US Dollar Japanese Yen, Australian Dollar US Dollar, Aluminium, Steel Futures. Read Newsquawk Voice Ltd (Ryan Anderson)'s ...

Shell (UK) ( ($GB:SHEL) ) has shared an announcement. Shell plc announced the purchase of its own shares as part of an existing buy-back programme ...

Record book, diversification achieved ◆ ‘Interesting spread’ as name recognition continues to grow ◆ Inaugural Aussie ...

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

The ALTDE 2025-1 Trust deal is split into $527.7 million and $55.1 million tranches that Fitch Ratings anticipates rating 'A' ...